Research on metacognition yields eight communication strategies for inoculating the public against harmful health myths when standard techniques fail or backfire.
Prebunking and Debunking in Fact-checking211 Check
Prebunking and Debunking in Fact-checking is a presentation by Emmanuel Bida Thomas at a webinar organised by 211 Check with support from the International Fact-checking Network.
This PDF file discusses the concepts of prebunking and debunking as methods of countering the spread of misinformation and false information. Prebunking refers to the practice of raising people's awareness of likely misinformation before they encounter it, while debunking occurs after false information has already been shared. The PDF also discusses different types of interventions that can be used to address misinformation at both individual and system levels.
There are enduring, almost perennial debates on the efficacy a.docxrorye
There are enduring, almost perennial debates on the efficacy and ethics of fear campaigns in
public health that reemerge with whack-a-mole frequency, as eloquently chronicled by Fairchild
et al. (p. 1180). Supported by evidence-based reasoning about motivating behavior change and
deterrence,1 these campaigns intentionally present disturbing images and narratives designed to
arouse fear, regr et, and disgust.
Having health problems can be a profoundly negative experience unappreciated by those not
living with them. Pain, immobility, disfigurement, depression, isolation, and financial problems
are common sequelae of disease and injury. It is beyond argument that these outcomes are self-
evidently anticipated and experienced as adverse, undesirable, and so best avoided. Efforts to
prevent them are therefore, prima facie, ethically beneficent and virtuous.
FIVE CRITICISMS
Criticism of the ethics of fear messaging takes five broad directions. First, it is often asserted that
fear campaigns should be opposed because they are ineffective: they simply "don't work" very
well. Fairchild et al. note that this argument persists despite the weight of evidence. The
ineffectiveness argument can be valid independent of the content of failed campaigns: "positive"
ineffective campaigns should be subject to the same criticism. Yet sustained criticism of
ineffective positive campaigns is uncommon, suggesting this criticism is enlisted to support more
primary objections about fear campaigns.
Second, critics argue that such campaigns target victims, not causes ofhealth problems, and so
are soft options mounted in lieu of more politically challenging upstream policy reform of social
determinants of health, such as education, employment, and income distribution as well as
legislative, fiscal, and product safety law reforms.
It is difficult to recall any major prescription for prevention in the past 40 years not involving
advocacy of comprehensive strategies of both policy reforms and motivational interventions. For
example, tobacco control advocates target advertising bans, smoke-free policies, and tax hikes as
well as increased public awareness campaign financing. When governments fail to enact
comprehensive approaches to prevention, supporting only public awareness campaigns, it is
plainly concerning. The resultant concentration of public discourse on the importance of
individualistic change instead of systemic, legislative, or regulatory change in controlling health
problems may lead to public perceptions that solutions are mostly contingent on what individuals
do or do not do.2 This myopic definition of health problems and their solution promotes victim
blaming,3 in which notions of individual responsibility are held to explain all health problems
when any volitional component is involved.
This can be a serious criticism of governments' failure to commit to prevention, but is it a fair
and sens.
Manifestation and Law of Attraction are not different concepts. Various people have already aware of them. Some of them have been working on these concepts to achieve new goals while others fail to get a result from them.
Prebunking and Debunking in Fact-checking211 Check
Prebunking and Debunking in Fact-checking is a presentation by Emmanuel Bida Thomas at a webinar organised by 211 Check with support from the International Fact-checking Network.
This PDF file discusses the concepts of prebunking and debunking as methods of countering the spread of misinformation and false information. Prebunking refers to the practice of raising people's awareness of likely misinformation before they encounter it, while debunking occurs after false information has already been shared. The PDF also discusses different types of interventions that can be used to address misinformation at both individual and system levels.
There are enduring, almost perennial debates on the efficacy a.docxrorye
There are enduring, almost perennial debates on the efficacy and ethics of fear campaigns in
public health that reemerge with whack-a-mole frequency, as eloquently chronicled by Fairchild
et al. (p. 1180). Supported by evidence-based reasoning about motivating behavior change and
deterrence,1 these campaigns intentionally present disturbing images and narratives designed to
arouse fear, regr et, and disgust.
Having health problems can be a profoundly negative experience unappreciated by those not
living with them. Pain, immobility, disfigurement, depression, isolation, and financial problems
are common sequelae of disease and injury. It is beyond argument that these outcomes are self-
evidently anticipated and experienced as adverse, undesirable, and so best avoided. Efforts to
prevent them are therefore, prima facie, ethically beneficent and virtuous.
FIVE CRITICISMS
Criticism of the ethics of fear messaging takes five broad directions. First, it is often asserted that
fear campaigns should be opposed because they are ineffective: they simply "don't work" very
well. Fairchild et al. note that this argument persists despite the weight of evidence. The
ineffectiveness argument can be valid independent of the content of failed campaigns: "positive"
ineffective campaigns should be subject to the same criticism. Yet sustained criticism of
ineffective positive campaigns is uncommon, suggesting this criticism is enlisted to support more
primary objections about fear campaigns.
Second, critics argue that such campaigns target victims, not causes ofhealth problems, and so
are soft options mounted in lieu of more politically challenging upstream policy reform of social
determinants of health, such as education, employment, and income distribution as well as
legislative, fiscal, and product safety law reforms.
It is difficult to recall any major prescription for prevention in the past 40 years not involving
advocacy of comprehensive strategies of both policy reforms and motivational interventions. For
example, tobacco control advocates target advertising bans, smoke-free policies, and tax hikes as
well as increased public awareness campaign financing. When governments fail to enact
comprehensive approaches to prevention, supporting only public awareness campaigns, it is
plainly concerning. The resultant concentration of public discourse on the importance of
individualistic change instead of systemic, legislative, or regulatory change in controlling health
problems may lead to public perceptions that solutions are mostly contingent on what individuals
do or do not do.2 This myopic definition of health problems and their solution promotes victim
blaming,3 in which notions of individual responsibility are held to explain all health problems
when any volitional component is involved.
This can be a serious criticism of governments' failure to commit to prevention, but is it a fair
and sens.
Manifestation and Law of Attraction are not different concepts. Various people have already aware of them. Some of them have been working on these concepts to achieve new goals while others fail to get a result from them.
Understanding Uncertainty Management Theory by Dale Brashers in the health communication context. It seeks to improve one's ability to communicate effectively by bringing feelings of doubt and anxiety down to more manageable levels.
The epidemic of misinformation about vaccinesCILIP
Dr Pauline Paterson's (Research Fellow and co-director of The Vaccine Confidence Project, London School of Hygiene & Tropical Medicine) presentation at the CILIP 2017 Conference in Manchester #CILIPConf17
Whilst most people vaccinate, some groups or individuals delay or refuse vaccines due to concerns about safety, whether real or perceived, and concerns about information (including mis-information or mis-trust in information). Public concerns about vaccines have occurred around the world, spreading quickly and sometimes leading to vaccine refusals and disease outbreaks.
The presentation will explore case studies on non-vaccination of measles containing vaccine (MCV) and concerns around HPV vaccine globally. This talk will attempt to address the question of how misinformation can undermine public health, exploring selective exposure, selective perception and the issue of multiple realities.
A mock opinion piece on the Singularity and the future of healthcare for the Trillion Dollar Challenges class. Explores the relationship between health technology and human interaction.
It is a universal truth that children must be given the appropriate vaccine at the appropriate age. Providing various vaccines at a given age saves kids from diseases that are life-threatening. Until and unless the kids are informed about the health hazards, they won’t realize the vaccine awareness they should be having.
Three skills for GPs to address the infodemicTina Purnat
A workshop for General Practitioners on practical skills on adressing the infodemic.
The presentation contains videos - to watch them, you need to download the presentation to your own computer, open in Powerpoint, "enable content", and then play the videos embedded in the slides.
Well Informed Patients are More EngagedJim Cucinotta
Studies show that well informed patients are more engaged in their health. They are more receptive to learning how to live healthier and manage their disease states properly. Invest in your patients and they will invest in their health.
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cell
R3 Stem Cells and Kidney Repair: A New Horizon in Nephrology" explores groundbreaking advancements in the use of R3 stem cells for kidney disease treatment. This insightful piece delves into the potential of these cells to regenerate damaged kidney tissue, offering new hope for patients and reshaping the future of nephrology.
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...The Lifesciences Magazine
Deep Leg Vein Thrombosis occurs when a blood clot forms in one or more of the deep veins in the legs. These clots can impede blood flow, leading to severe complications.
Explore our infographic on 'Essential Metrics for Palliative Care Management' which highlights key performance indicators crucial for enhancing the quality and efficiency of palliative care services.
This visual guide breaks down important metrics across four categories: Patient-Centered Metrics, Care Efficiency Metrics, Quality of Life Metrics, and Staff Metrics. Each section is designed to help healthcare professionals monitor and improve care delivery for patients facing serious illnesses. Understand how to implement these metrics in your palliative care practices for better outcomes and higher satisfaction levels.
The Importance of Community Nursing Care.pdfAD Healthcare
NDIS and Community 24/7 Nursing Care is a specific type of support that may be provided under the NDIS for individuals with complex medical needs who require ongoing nursing care in a community setting, such as their home or a supported accommodation facility.
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondHealth Catalyst
Join us as we delve into the crucial realm of quality reporting for MSSP (Medicare Shared Savings Program) Accountable Care Organizations (ACOs).
In this session, we will explore how a robust quality management solution can empower your organization to meet regulatory requirements and improve processes for MIPS reporting and internal quality programs. Learn how our MeasureAble application enables compliance and fosters continuous improvement.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Dr. David Greene Arizona
As we watch Dr. Greene's continued efforts and research in Arizona, it's clear that stem cell therapy holds a promising key to unlocking new doors in the treatment of kidney disease. With each study and trial, we step closer to a world where kidney disease is no longer a life sentence but a treatable condition, thanks to pioneers like Dr. David Greene.
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
the IUA Administrative Board and General Assembly meeting
How to combat misinformation on vaccines and other public health issues
1. APRIL. 15. 2015
HOW TO COMBAT
MISINFORMATION
ON VACCINES & OTHER PUBLIC HEALTH ISSUES
WILLAM D. LEACH, PHD
SOL PRICE SCHOOL OF PUBLIC POLICY
UNIVERSITY OF SOUTHERN CALIFORNIA
2. USC Provost Professor
Norbert Schwarz studies the
psychology of metacognition
– meaning our thoughts about
what we think and why – and
it's application to harmful
misconceptions about health
and wellbeing.
Drawing upon a decade of research, this presentation reviews why
standard mythbusting campaigns backfire, and what we should do
instead to combat harmful health myths while communicating
accurate health information.
3. Truth-Testing Heuristics
People are more likely to believe new information if it satisfies
five metacognitive criteria:
1. Compatibility: Is it compatible with other things I know?
2. Coherence: Is it an internally coherent and plausible story?
3. Credibility: Does it come from a credible source?
4. Corroboration: Is there a lot of supporting evidence?
5. Consensus: Do others believe this?
4. Eight Communication Strategies for
Effective Public Health Campaigns
Takehome messages from research on metacognition are
summarized in the following eight communication strategies.
5. #1
Do not repeat misinformation.
“False information is better left alone. Any
attempt to explicitly discredit false information
necessarily involves a repetition of the false
information, which may contribute to its later
familiarity and acceptance” (Schwarz et al. 2007).
Therefore, to fight misinformation on vaccines, it
is best to ignore the misinformants, and instead
focus on communicating the risks of preventable
infections and the benefits of vaccination.
6. #2
Repeat “true facts” often.
Repetition increases familiarity and implies that a
claim is widely accepted. Ideally, multiple credible
sources should repeat the same information, but
failing that, simply having the same authority repeat
the same message increases perceptions of
consensus and veracity (Schwarz 2015).
7. #3
Enlist credible sources.
Heuristic #3 highlights the importance of credibility.
However, highly credible sources should be especially
careful not to repeat a myth. People may later associate
the myth with the credible source, but forget that the
information is untrue.
8. #4
Lead with a disclaimer.
If misinformation must be repeated, explicitly warn the
audience ahead of time that they are about to hear something
that merits skepticism. The best protection against harmful
health misconceptions is suspicion when you first hear it. For
example, the FDA requires that labels for dietary supplements
include the disclaimer, “This product is not intended to
diagnose, treat, cure, or prevent any disease.” Moving this
message to the top of label and the beginning of radio
advertisements would enhance its impact.
9. #5
Emphasize consensus
on the true information.
Heuristic #5 implies one should emphasize consensus
on true information and avoid signaling consensus on
false information. News reports on health myths, such
as the unfounded link between childhood vaccines
and autism, unavoidably normalize mistaken beliefs
by suggesting they are commonly held.
10. #6
Make the message simple,
brief, and memorable.
Simple fonts, clear language, brevity, and white space on
the page help the audience feel as though they understand
the message effortlessly. Rhymes, jingles, mnemonics,
and visuals make a message memorable. “If the myth is
simpler and more compelling than your debunking, it will
be cognitively more attractive” (Lewandowsky et al. 2012).
11. #7
Affirm the audience's worldview.
People rarely accept new information that contradicts their
existing beliefs. To soften resistance, validate the audience’s
basic values. For example, people who fear childhood vacci
nation and distrust the government or the pharmaceutical
industry might be more receptive to vaccine information
from an independent nonprofit organization dedicated to
children’s health, especially if vaccination is framed as a
voluntary action taken by thoughtful parents who have
thoroughly investigated the pros and potential cons.
12. #8
Nudge toward better decisions.
Policymakers can often design “choice architecture” so that
people automatically gravitate toward the preferred decision.
A promising example from behavioral economics is the use of
defaults . For example, many people never skip a sixmonth dental
checkup, largely because dental offices always schedule your
next visit before you leave the office. If family physicians routinely
calendared their patients’ annual flu vaccine, vaccination rates
might rise accordingly. Flipping the default choice would improve
public health without altering patients’ basic options and without
confronting misinformation about vaccines.
13. GET THE FULL STORY AT USC'S
Executive Master's of Health Administration
http://exechealthadmin.usc.edu/blog